Synovics Pharmaceuticals, Inc.
SYVC
$0.00
$0.000.00%
OTC PK
| 07/31/2009 | 04/30/2009 | 01/31/2009 | 10/31/2008 | 07/31/2008 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -69.51% | -57.53% | 1,860.00% | -- | -83.26% |
| Total Receivables | -58.34% | -19.35% | 92.85% | 14.76% | -0.70% |
| Inventory | 5.50% | -6.44% | 98.41% | 50.50% | 5.00% |
| Prepaid Expenses | 33.93% | 0.14% | 39.53% | 24.56% | -11.58% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -31.63% | -12.94% | 88.89% | 28.88% | -23.57% |
|
|
|||||
| Total Current Assets | -31.63% | -12.94% | 88.89% | 28.88% | -23.57% |
| Net Property, Plant & Equipment | -10.22% | 10.81% | 11.71% | 22.68% | 8.30% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -34.20% | -68.52% | -65.80% | -64.76% | -68.07% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -95.40% | -95.60% | -83.05% | -73.68% | -36.56% |
| Total Assets | -20.40% | -18.80% | 2.62% | -4.23% | -15.58% |
|
|
|||||
| Total Accounts Payable | 28.71% | 24.57% | 51.04% | 26.74% | 33.34% |
| Total Accrued Expenses | 15.73% | -55.73% | -49.16% | -37.38% | -40.16% |
| Short-term Debt | -30.54% | -96.57% | -95.45% | -93.63% | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 43.22% | 54.07% | 2.29% | -54.28% | -83.74% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 24.12% | -46.56% | -43.63% | -46.04% | -36.03% |
|
|
|||||
| Total Current Liabilities | 24.12% | -46.56% | -43.63% | -46.04% | -36.03% |
| Long-Term Debt | -60.92% | -50.00% | -39.39% | -34.86% | -52.97% |
| Short-term Debt | -30.54% | -96.57% | -95.45% | -93.63% | -- |
| Capital Leases | 13.41% | 72.95% | 53.66% | 140.08% | 96.95% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | 0.00% |
| Total Liabilities | -0.27% | -47.68% | -43.77% | -44.83% | -39.40% |
|
|
|||||
| Common Stock & APIC | 1.67% | 14.92% | 31.76% | 18.49% | 18.24% |
| Retained Earnings | -7.72% | -4.23% | -4.57% | -5.91% | -12.71% |
| Treasury Stock & Other | -3.47% | 68.29% | -78.80% | 68.19% | 69.26% |
| Total Common Equity | -150.69% | 104.47% | 128.84% | 146.88% | 160.73% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.39% | 3.63% | 3.63% | 3.63% | 3.23% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.39% | 3.63% | 3.63% | 3.63% | 3.23% |
|
|
|||||
| Total Common Equity | -150.69% | 104.47% | 128.84% | 146.88% | 160.73% |
| Total Preferred Equity | 0.39% | 3.63% | 3.63% | 3.63% | 3.23% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -119.41% | 112.58% | 139.09% | 161.72% | 190.49% |
|
|
|||||